Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acidowipe Kid Suspension is a pediatric gastrointestinal formulation developed and marketed by Fealth Life Care. It is a fixed-dose combination of simethicone, dill oil, and fennel oil, primarily indicated for the relief of infantile colic, flatulence, abdominal pain, and gas in infants and children. Simethicone functions as an antifoaming agent that reduces the surface tension of gas bubbles in the stomach and intestines, enabling them to coalesce into larger bubbles that can be passed more easily. Dill oil and fennel oil are natural carminatives and antispasmodics that help soothe the digestive tract, relax intestinal smooth muscle, and facilitate the expulsion of trapped gas.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Acidowipe Kid Suspension.